menveo meningococcal (groups a, c, w-135 and y) oligosaccharide crm197 conjugate vaccine
glaxosmithkline australia pty ltd - meningococcal oligosaccharide group y, quantity: 5 microgram; meningococcal oligosaccharide group c, quantity: 5 microgram; diphtheria crm197 protein, quantity: 16 microgram; meningococcal oligosaccharide group w135, quantity: 5 microgram - injection, solution - excipient ingredients: sodium chloride; water for injections; monobasic sodium phosphate monohydrate; dibasic sodium phosphate dihydrate - menveo is indicated for active immunisation of infants and children (from 2 months of age), adolescents and adults to prevent invasive disease caused by neisseria meningitidis serogroups a, c, w-135 and y. the use of this vaccine should be in accordance with official recommendations.
rabisin
boehringer ingelheim vetmedica gmbh - rabies virus glycoprotein - suspension for injection - . - rabies virus
kamrab solution
kamada ltd - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums
kamrab solution
kamada ltd - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums
hyperrab solution
grifols therapeutics llc - rabies immunoglobulin (human) - solution - 300unit - rabies immunoglobulin (human) 300unit - serums
verorab vaccine
sanofi-aventis (malaysia) sdn. bhd. - inactivated rabies virus -
pr-vac plus formulation: each 2 ml of reconstituted vaccine contains: modified live pseudorabies virus vaccine (bucharest strain) * tcid, 50% endpoint 1045tcid50* lyophilized powder for injection (im)
zoetis philippines, inc. - modified live pseudorabies virus vaccine - lyophilized powder for injection (im) - formulation: each 2 ml of reconstituted vaccine contains: modified live pseudorabies virus vaccine (bucharest strain) * tcid, 50% endpoint 1045tcid50*
bayovac r each ml contains: rabies virus (sad vnukovo-32 strain).. iu - intemational unit >2 iu suspension for injection (im/sc)
elanco philippines, inc. - inactivated rabies virus vaccine (vet.) - suspension for injection (im/sc) - each ml contains: rabies virus (sad vnukovo-32 strain).. iu - intemational unit >2 iu
auskipra gn formulation: each 2 ml (dose) contains: pseudorabies (aujeszky's disease) virus (bartha k61 ge negative strain).... > 10 ^5.5 ccid 50 ccid-cell culture infective dose freeze-dried powder for injection (intranasal/im)
hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated pseudorabies (aujeszky's disease) virus vaccine (vet.) - freeze-dried powder for injection (intranasal/im) - formulation: each 2 ml (dose) contains: pseudorabies (aujeszky's disease) virus (bartha k61 ge negative strain).... > 10 ^5.5 ccid 50 ccid-cell culture infective dose
porcilis begonia formulation: each dose contains: pseudorabies (aujeszky's) disease virus (begonia strain) .... > 10^5.5 tcid50 tcid-tissue culture infective dose freeze-dried powder for injection (id/im)
msd animal health (phils.), inc. - live pseudorabies (aujeszky's) disease virus vaccine (vet.) - freeze-dried powder for injection (id/im) - formulation: each dose contains: pseudorabies (aujeszky's) disease virus (begonia strain) .... > 10^5.5 tcid50 tcid-tissue culture infective dose